In vitro induction of specific cytotoxic T lymphocytes using recombinant single-chain MHC class I’peptide complexes

Journal of Immunotherapy

Volumn 21, Issue 4, 1998, Pages 283-294

  Lone, Yu Chun ^a   Motta, Iris ^a   Mottez, Estelle ^a   Guilloux, Yannik ^a   Lim, Annick ^a   Demay, Frédéric ^a   Levraud, Jean Pierre ^a   Kourilsky, Philippe ^a   Abastado, Jean Pierre ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Clonal expansion; Cytotoxic T lymphocytes; Major histocompatibility complex

Indexed keywords

BETA 2 MICROGLOBULIN; HLA A2 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE REARRANGEMENT; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT;

EID: 0031847762     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199807000-00006     Document Type: Article

References (63)

1. Townsend ARM, Gotch FM, Davey J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 1985;42:457-67.
2. Rammensee HG, Falk K, Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993; 11;213-44.
3. Germain R, Margulies D. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993;11: 403-50.
4. Matsumura M, Fremont DH, Peterson PA, Wilson IA. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 1992;257:927-34.
5. Sette A, Vitiello A, Reherman B, et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994;153:5586-92.
6. Quesnel A, Hsu SC, Delmas A, Steward MW, Trudelle Y, Abastado JP. Efficient binding to the MHC class I K(d) molecule of synthetic peptides in which the anchoring position 2 does not fit the consensus motif. FEBS Lett 1996;387:42-6.
7. d fused to pS2-microglobulin expressed in the baculo/insect cell system. J Biol Chem 1992;267:24223-9.
8. Mottez E, Jaulin C, Godeau F, Choppin J, Levy J-P, Kourilsky P. A single-chain murine class I major transplantation antigen. Eur J Immunol 1991;21:467-71.
9. Ojcius D, Godeau F, Abastado J-P, Casanova J-L, Kourilsky P. Real-time measurement of antigenic peptide binding to empty and preloaded single-chain MHC class I molecules. Eur J Immunol 1993;23:1118-24.
10. d. Eur J Immunol 1993;23:1776-83.
11. Abastado JP, Lone YC, Casrouge A, Boulot G, Kourilsky P. Dimerization of soluble MHC-peptide complexes is sufficient for activation of T-cell hybridoma and induction of unresponsiveness. J Exp Med 1995;182:439-47.
12. Katahira Y, Yashiki S, Fujiyoshi T, et al. In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn J Cancer Res 1995;86:21-7.
13. Celis E, Tsai V, Crimi C, et al. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci USA 1994;91:2105-9.
14. Banks TA, Nair S, Rouse BT. Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus. J Virol 1993;67:613-6.
15. Houbiers JG, Nijman HW, van der Burg SH, et al. In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur J Immunol 1993;23:2072-7.
16. De Braijn M, Nieland JD, Schumacher TN, Ploegh HL, Kast WM, Melief CJ. Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses. Eur J Immunol 1992;22:3013-20.
17. Bellone M, Iezzi G, Manfredi AA, et al. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells. Eur J Immunol 1994;24:2691-8.
18. Langlade-Demoyen P, Levraud J-P, Kourilsky P, Abastado J-P. Primary CTL induction using peptide stripped autologous cells, bit Immunol 1994;6:1759-66.
19. Mottez E, Langlade-Demoyen P, Goumier H, et al. Cells expressing an MHC class I molecule with a single covalently bound peptide are highly immunogenic. J Exp Med 1994;181:493-502.
20. Nair S, Babu JS, Dunham RG, Kanda P, Burke RL, Rouse BT. Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells. J Virol 1993;67:4062-9.
21. Gagliardi M, De Petrillo G, Salemi S, et al. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Ini Immunol 1995;7:1741-52.
22. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-81.
23. Even J, Lim A, Puisieux I, et al. T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res Immunol 1995;146:65-80.
24. Liabeuf A, le Borgne de Kaouel C, Kourilsky FM, Malissen B, Manuel Y, Sanderson AR. An antigenic determinant of human beta 2-microglobulin masked by the association with HLA heavy chains at the cell surface: analysis using monoclonal antibodies. J Immunol 1981;127:1542-8.
25. McMichael AJ, Parham P, Rust N, Brodsky F. A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum Immunol 1980;1:121-9.
26. Parham P, Brodsky FM. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 1981;3:277-99.
27. Parham P, Bodmer WF. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature 1978;276:397-9.
28. Smith DM, Bluestone JA, Jeyarajah DR, et al. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. J Immunol 1994;153: 1054-67.
29. Engel I, Ottenhoff T, Klausner R. High-efficiency expression and solubilization of functional T cell antigen receptor heterodimers. Science 1992;256:1318-21.
30. Maryanski J, Accolla R, Jordan B. H-2-restricted recognition of cloned HLA class I gene products expressed in mouse cells. J Immunol 1986;136:4340-7.
31. Suggs SV, Wallace RB, Hirose T, Kawashima EH, Itakura K. Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin. Proc Natl Acad Sci USA 1981;78:6613-7.
32. Ennis PD, Zemmour J, Salter RD, Parham P. Rapid cloning of HLA-A, B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc Natl Acad Sci USA 1990;87:2833-7.
33. Ruppert J, Sidney J, Celis E, Kubo R, Grey H, Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 1993;74:929-37.
34. Hunter WM, Greenwood F. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962;194: 495-6.
35. Guilloux Y, Lucas S, Brichard VG, et al. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the iV-acetylglucosaminyltransferase V gene. J Exp Med 1996;183:1173-83.
36. Coligan J, Kruisbeck A, Margulies D, Shevach E, Strober W. Current protocols in immunology. Boston: Wiley, 1993.
37. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 1993;90:4319-23.
38. Ojcius D, Abastado J-P, Casrouge A, Mottez E, Kourilsky P. Dissociation of peptide-MHC class I complex limits the binding rate of exogenous peptide. J Immunol 1993;151:6020-6.
39. Gervois N, Guilloux Y, Diez E, Jotereau F. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J Exp Med 1996; 183: 2403-7.
40. Engelhard V. Structure of peptides associated with MHC class I molecules. Curr Opin Immunol 1994;6:13-23.
41. Rotzschke O, Falk K, Deres K, et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990;348:252-4.
42. Macatonia SE, Taylor PM, Knight SC, Askonas BA. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med 1989;169:1255-64.
43. Bednarek MA, Sauma SY, Gammon MC, et al. The minimum peptide epitope from the influenza virus matrix protein-extra and intracellular loading of HLA-A2. J Immunol 1991;147:4047-53.
44. Morrison J, Elvin J, Latron F, et al. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur J Immunol 1992;22:903-7.
45. Coulie PG, Brichard V, van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42.
46. Kawakami Y, Eliyahu S, Delgado CH, et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994;91:6458-62.
47. Cibotti R, Cabaniols JP, Pannetier C, et al. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J Exp Med 1994;180:861-72.
48. Casanova JL, Cerottini JC, Matthes M, et al. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J Exp Med 1992;176:439-47.
49. MacDonald H, Casanova J, Maryanski J, Cerottini J. Oligoclonal expansion of MHC class I-restricted CTLs during a primary immune response in vivo: direct monitoring by flow cytometry and polymerase chain reaction. J Exp Med 1993;177:1487-92.
50. Maryanski JL, Jongeneel CV, Bucher P, Casanova JL, Walker PR. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity 1996;4:47-55.
51. Walker P, Ohtelci T, Lopez J, MacDonald H, Maryanski J. Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response. J Immunol 1995; 155:3443-52.
52. Moss PA, Moots RJ, Rosenberg WM, et al. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA 1991;88:8987-90.
53. Lehner PJ, Wang EC, Moss PA, et al. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 1995;181:79-91.
54. b at the cell surface. J Immunol 1994;153:5068-81.
55. Toshitani K, Braud V, Browning MJ, Murray N, McMichael AJ, Bodmer WF. Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1996; 93:236-40.
56. Lee L, Loftus D, Appella E, Margulies DH, Mage M. A recombinant single-chain HLA-A2.1 molecule, with a cis active beta-2-microglobulin domain, is biologically active in peptide binding and antigen presentation. Hum Immunol. 1996;49:28-37.
57. Wentworth PA, Celis E, Crimi C, et al. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol Immunol 1995;32:603-12.
58. Carbone FR, Moore MW, Sheil JM, Bevan MJ. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J Exp Med 1988;167:1767-79.
59. Speiser DE, Kyburz D, Stubi U, Hengartner H, Zinkernagel RM. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. J Immunol 1992;149:972-80.
60. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee H. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991;351:290-6.
61. van der Bruggen P, Bastin J, Gajewski T, et al. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 1994;24:3038-43.
62. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995;41:178-228.
63. Chothia C, Boswell Dr, Lesk AM. The outline structure of the T-cell alpha beta receptor. EMBO J 1988;7:3745-55.